In 1955, Jonas Salk announced a working polio vaccine. Within two years, polio cases in the US dropped by 85–90%. A disease that had paralysed hundreds of thousands of children per year — including a future US president — was being dismantled by a syringe. This lesson is about how that is possible, and why it sometimes isn't.
Use the PDF for classwork, homework or revision. It includes key ideas, activities, questions, an extend task and success-criteria proof.
In 1952, the United States recorded 57,879 polio cases — the worst outbreak in American history. Children were placed in iron lungs to breathe. Pools, cinemas, and libraries closed every summer in fear. By 1961, cases had fallen to 161.
Before reading: what do you think a successful mass vaccination program actually does to a disease at the population level — not just the individual level? How does vaccinating individuals change the fate of the pathogen itself?
Come back to this at the end of the lesson.
Wrong: Natural selection means organisms change because they want or need to.
Right: Natural selection acts on random genetic variations; organisms do not consciously adapt.
Core Content
Immunity can be classified along two axes: how it was acquired (natural or artificial) and what type it is (active or passive). Understanding this framework is essential for the HSC — exam questions frequently test whether students can correctly classify a given scenario.
The two-axis framework — always classify immunity by both axes: active vs passive, AND natural vs artificial
When enough individuals in a population are immune to a pathogen, transmission chains break — even susceptible (unvaccinated or uninfected) individuals are protected because the pathogen cannot find enough hosts to spread. This is herd immunity (also called population immunity or community immunity).
Herd immunity protects unvaccinated individuals by surrounding them with immune people — the pathogen cannot find a transmission chain
The proportion of a population that must be immune to achieve herd immunity depends on the pathogen's basic reproduction number (R₀) — the average number of people one infected person infects in a fully susceptible population. The higher the R₀, the higher the immunity threshold required.
| Disease | R₀ (approx.) | Herd Immunity Threshold | Status |
|---|---|---|---|
| Measles | 12–18 | ~95% | Eliminated in many countries; outbreaks where coverage drops |
| Polio | 5–7 | ~80–85% | Near-eradicated globally; endemic in Pakistan and Afghanistan |
| Smallpox | 5–7 | ~80–85% | Eradicated 1980 |
| COVID-19 (original strain) | 2–3 | ~50–67% | Threshold raised by variants with higher R₀ |
| Influenza (seasonal) | 2–3 | ~50–67% | Annual vaccination required due to antigenic variation |
| Pertussis (whooping cough) | 12–17 | ~92–94% | Resurgent in populations with declining booster rates |
Vaccination programs can achieve three levels of disease control, depending on coverage, vaccine effectiveness, and pathogen characteristics.
Eradication is extraordinarily difficult. The conditions that allowed smallpox eradication were almost uniquely favourable: no animal reservoir, obvious visible symptoms, a stable highly effective vaccine, and a virus that did not mutate rapidly. Diseases that resist eradication typically have one or more of the following features:
Polio was one of the most feared diseases of the 20th century — largely because it preferentially struck children, was highly visible (iron lungs, leg braces, wheelchairs), and had no effective treatment. Franklin D. Roosevelt, who contracted polio in 1921, co-founded the National Foundation for Infantile Paralysis in 1938 — later renamed the March of Dimes after comedian Eddie Cantor suggested Americans send their dimes directly to the White House. The campaign raised millions for research and directly funded Jonas Salk's work on an inactivated polio vaccine. On April 12, 1955 — exactly ten years after Roosevelt's death — Salk's vaccine was declared "safe, effective, and potent." Americans wept in the streets. Church bells rang. Within two years, polio cases dropped by 85–90%. By 1961, Albert Sabin's oral attenuated vaccine was licensed — easier to administer globally. Polio has since been eliminated from every country except Pakistan and Afghanistan, where vaccination campaigns continue despite security challenges.
The gap between 350,000 cases per year and fewer than 20 is a direct measure of what sustained vaccination programs achieve at the population level. You will evaluate vaccination program effectiveness using data in Activity 02 and Short Answer Q3.
Misconception: Herd immunity means everyone is immune — only unvaccinated people can break it.
Herd immunity is a population threshold, not universal immunity. It means enough people are immune to prevent sustained transmission chains. Unvaccinated individuals are one source of susceptibility, but so are vaccine non-responders, immunocompromised individuals who cannot mount a full response to vaccination, and recently vaccinated individuals whose immunity has waned below the protective threshold. Herd immunity can be eroded by any increase in the proportion of susceptible individuals — not just deliberate vaccine refusal.
Misconception: Once a country achieves elimination, vaccination is no longer needed.
Elimination (zero local transmission) does not mean eradication (global extinction). As long as a pathogen exists anywhere in the world, importation events can re-establish transmission in under-vaccinated populations. Australia eliminated measles — but unvaccinated individuals regularly acquire measles overseas and return, and if vaccination rates have slipped below the herd immunity threshold in any community, a local outbreak can follow. Vaccination must continue until global eradication is achieved.
Misconception: Natural infection always provides better immunity than vaccination, so natural infection is preferable to vaccination.
For some pathogens, natural infection does produce broader or more durable immunity — but the comparison ignores the cost. Natural polio infection paralysed hundreds of thousands of children. Natural measles causes encephalitis in 1 in 1,000 cases. Natural chickenpox can cause fatal pneumonia in adults and leaves latent varicella-zoster virus that causes shingles decades later. The immunity gained from natural infection does not justify the disease risk — especially when vaccination can produce equivalent or superior immunity with a fraction of the risk.
Herd Immunity — High vs Low Coverage
Activities
In your book, draw and annotate a diagram showing all four types of immunity using the two-axis framework (active/passive × natural/artificial). For each quadrant:
Type any notes here after completing your diagram.
The table below shows measles vaccination coverage and annual case numbers in a hypothetical country over 15 years.
| Year | Vaccination coverage (%) | Measles cases (annual) |
|---|---|---|
| 1 | 55 | 8,200 |
| 3 | 68 | 4,400 |
| 5 | 80 | 1,100 |
| 7 | 88 | 310 |
| 9 | 95 | 12 |
| 11 | 97 | 3 |
| 12 | 91 | 480 |
| 13 | 89 | 1,240 |
| 14 | 93 | 210 |
| 15 | 96 | 8 |
Write your responses here or in your book.
You were asked what a successful mass vaccination program actually does to a disease at the population level — and how vaccinating individuals changes the fate of the pathogen itself.
The answer: vaccination changes the proportion of susceptible individuals in the population. Below the herd immunity threshold, the pathogen can find enough susceptible hosts to sustain transmission — each infected person, on average, infects at least one other. Above the threshold, transmission chains break — infected individuals are increasingly surrounded by immune people who cannot be infected, and the chain dies out. The pathogen's "reproductive rate" effectively falls below 1.
As vaccination coverage rises through the threshold, the effect on case numbers is non-linear — a small increase in coverage near the threshold produces a disproportionately large reduction in cases. This is why the measles data in Activity 02 shows dramatic drops near the 95% threshold. And it explains why small drops in coverage below the threshold produce rapid outbreaks — the pathogen's effective reproduction number crosses back above 1.
If you predicted "fewer people get sick" — correct at the individual level. The population-level insight is that the pathogen's ability to persist depends entirely on finding susceptible hosts. Enough immunity in a population and the virus simply runs out of places to go.
Assessment
5 random questions from a replayable lesson bank — feedback shown immediately
1. Using two specific examples, explain the difference between natural passive immunity and artificial passive immunity. For each, describe how the antibodies are acquired and explain why protection is temporary. (3 marks)
1 mark: natural passive — correct example (maternal IgG via placenta or IgA via breast milk) and mechanism | 1 mark: artificial passive — correct example (antivenom, immunoglobulin) and mechanism | 1 mark: explanation of why both are temporary (no memory cells formed; antibodies catabolised)
2. Explain the concept of herd immunity, including how the herd immunity threshold is determined and why it differs between diseases. Use measles and polio as examples. (3 marks)
1 mark: herd immunity correctly defined (enough immune individuals to break transmission chains) | 1 mark: threshold determined by R₀ (threshold = 1 − 1/R₀) | 1 mark: measles vs polio comparison — measles R₀ 12–18 → ~95%; polio R₀ 5–7 → ~80–85%
3. Evaluate the effectiveness of global polio vaccination programs, referring to the historical reduction in cases, the current status of eradication efforts, and the barriers that have prevented complete eradication. (4 marks)
1 mark: quantitative evidence of effectiveness (350,000 cases/year in 1988 → fewer than 20 now) | 1 mark: current status — eliminated from all countries except Pakistan and Afghanistan | 1 mark: barriers correctly identified (conflict, distrust, logistics — not vaccine failure or animal reservoir) | 1 mark: overall evaluative conclusion — highly effective program with remaining barriers non-biological
Answers
SA1: Natural passive immunity occurs when pre-formed antibodies are transferred from one individual to another through a natural biological process — without any medical intervention and without the recipient's immune system being activated. An example is the transfer of IgG antibodies from a pregnant mother to her foetus across the placenta during the third trimester. These antibodies provide the newborn with protection against pathogens the mother has encountered (through infection or vaccination) during the critical period before the infant's own adaptive immune system matures. Artificial passive immunity occurs when pre-formed antibodies are deliberately administered through a medical procedure. An example is antivenom — antibodies produced in horses or sheep that have been repeatedly exposed to snake venom. When a snakebite victim receives antivenom by injection, the antibodies immediately begin neutralising venom toxins circulating in the bloodstream. Both natural and artificial passive immunity are temporary because in neither case does the recipient's immune system mount its own response — no clonal selection occurs, no plasma cells are produced by the recipient, and no memory B or T cells are formed. The transferred antibodies are gradually catabolised (broken down) over weeks to months, and protection fades as their concentration declines.
SA2: Herd immunity (population immunity) occurs when a sufficient proportion of a population is immune to a pathogen — through vaccination or prior infection — that the pathogen cannot find enough susceptible hosts to sustain transmission chains. Even individuals who are not immune are protected because the pathogen cannot spread effectively through the population to reach them. The herd immunity threshold is determined by the pathogen's basic reproduction number (R₀) — the average number of people one infected person infects in a fully susceptible population. The relationship is: threshold = 1 − 1/R₀. A higher R₀ means each infected person infects more people, so a larger proportion of the population must be immune to prevent sustained spread. Measles has an R₀ of approximately 12–18 — one of the highest of any known human pathogen — meaning each case generates 12–18 secondary cases in a fully susceptible population. Applying the formula: threshold = 1 − 1/15 ≈ 93–95% of the population must be immune. By contrast, polio has an R₀ of approximately 5–7, giving a threshold of approximately 80–85%. This is why measles outbreaks occur rapidly when vaccination coverage drops even a few percent, while polio can be controlled at lower coverage levels.
SA3: The global polio vaccination program, launched through the WHO's Global Polio Eradication Initiative in 1988, has been one of the most successful public health interventions in history. In 1988 when the initiative began, polio was endemic in 125 countries and paralysed approximately 350,000 children per year. By 2024, wild poliovirus type 1 is endemic in only two countries — Pakistan and Afghanistan — with fewer than 20 cases per year globally. This represents a reduction of greater than 99.9% in global polio incidence. The program achieved certification of polio-free status in the Americas (1994), Western Pacific including Australia (2000), Europe (2002), South-East Asia including India (2014), and Africa (2020). The vaccine (both inactivated Salk vaccine and oral Sabin vaccine) has proven highly effective across all populations studied. The barriers that have prevented complete eradication are non-biological in nature. In Pakistan and Afghanistan, years of armed conflict have disrupted vaccination campaigns and displaced populations. Misinformation — including false claims linking the oral polio vaccine to infertility — generated distrust in some communities. Polio vaccination workers in both countries have been targeted in violent attacks, creating logistical and security barriers. These are geopolitical and social challenges, not failures of vaccine science or immunology. Overall, the global polio vaccination program represents an extraordinary success — demonstrating that sustained, coordinated vaccination at population scale can drive a globally endemic disease to the brink of eradication. The final 0.1% of the problem is a governance and security challenge, not an immunological one.